In the rapidly evolving landscape of healthcare, personalized medicine is making waves by offering tailored therapies that cater to the unique needs of individual patients. One of the most promising advancements in this field…
Continue Reading
What You Should Know: – Outpace Bio, a pioneering cell therapy company raises $144M in oversubscribed Series B financing round led by RA Capital Management with participation from both new and existing investors, including…
Continue Reading
What You Should Know:
– OverT Bio, a data-driven biotech company focused on unlocking the curative potential of cell therapies for solid tumors raises $16M in seed funding round. Co-led by ARTIS Ventures and Wing…
Continue Reading
A team at Columbia University School of Engineering and Applied Science has developed a technique to enhance chimeric antigen receptor (CAR) T cell therapy in solid tumors. The technique involves engineering E. coli bacteria,…
Continue Reading
Dr. Jose E Vidal who is currently the CEO of CytoImmune Therapeutics, a company at the forefront of a novel natural killer cell therapy for lung cancer, currently in phase 1 clinical trials joins…
Continue Reading
What You Should Know: Today, Rev1 Ventures, the venture studio that helps entrepreneurs and corporations accelerate innovation, Nationwide Children’s Hospital, and The Ohio State University announce expanded support for life sciences companies with the launch of Rev1 Catalyst…
Continue Reading
Robotic-assisted knee replacement surgery with laser technology is garnering attention as a groundbreaking advancement in orthopaedic care. With its array of benefits for patients and surgeons alike, this cutting-edge approach is transforming the landscape…
Continue Reading
CAR T-cell therapy is used to treat patients with blood cancers such as multiple myeloma. Since it can cause serious side effects, patients are usually hospitalized and monitored for up to two weeks after…
Continue Reading
Researchers at the Harvard Wyss Institute have developed an anti-cancer biomaterial treatment that combines adoptive T cell therapy and cancer vaccine technology to treat solid tumors. The researchers have called their technique SIVET, which…
Continue Reading
Researchers at the Harvard Wyss Institute have developed a new type of cell therapy for multiple sclerosis patients. The technique involves taking a blood sample from the patient being treated, isolating a sample of…
Continue Reading
